McDonald LC, Gerding DN, Johnson S, Bakken JS, Carroll KC, Coffin SE, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the infectious diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987–94. https://doi.org/10.1093/cid/ciy149.
Article
CAS
PubMed
Google Scholar
Thabit AK, Housman ST, Burnham CD, Nicolau DP. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection. J Hosp Infect. 2016;92(2):167–72. https://doi.org/10.1016/j.jhin.2015.11.009.
Article
CAS
PubMed
Google Scholar
Czepiel J, Drozdz M, Pituch H, Kuijper EJ, Perucki W, Mielimonka A, et al. Clostridium difficile infection: review. Eur J Clin Microbiol Infect Dis. 2019;38(7):1211–21. https://doi.org/10.1007/s10096-019-03539-6.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thabit AK, Varugehese CA, Levine AR. Antibiotic use and duration in association with Clostridioides difficile infection in a tertiary academic medical center: a retrospective case-control study. Anaerobe. 2019;59:126–30. https://doi.org/10.1016/j.anaerobe.2019.06.016.
Article
PubMed
Google Scholar
Leffler DA, Lamont JT. Clostridium difficile infection. N Engl J Med. 2015;372(16):1539–48. https://doi.org/10.1056/NEJMra1403772.
Article
CAS
PubMed
Google Scholar
Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother. 2012;67(3):742–8. https://doi.org/10.1093/jac/dkr508.
Article
CAS
PubMed
Google Scholar
Johnson S, Samore MH, Farrow KA, Killgore GE, Tenover FC, Lyras D, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med. 1999;341(22):1645–51. https://doi.org/10.1056/nejm199911253412203.
Article
CAS
PubMed
Google Scholar
Al-Tawfiq JA, Abed MS. Clostridium difficile-associated disease among patients in Dhahran, Saudi Arabia. Travel medicine and infectious disease. 2010;8(6):373–6. https://doi.org/10.1016/j.tmaid.2010.10.003.
Article
PubMed
Google Scholar
Al-Tawfiq JA, Rabaan AA, Bazzi AM, Raza S, Noureen M. Clostridioides (Clostridium) difficile-associated disease: epidemiology among patients in a general hospital in Saudi Arabia. Am J Infect Control. 2020. https://doi.org/10.1016/j.ajic.2020.01.011.
Article
PubMed
Google Scholar
Alzouby S, Baig K, Alrabiah F, Shibl A, Al-Nakhli D, Senok AC. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh. Saudi Arabia J Infect Public Health. 2020;13(7):1012–7. https://doi.org/10.1016/j.jiph.2019.10.014.
Article
PubMed
Google Scholar
Malekzadegan Y, Halaji M, Hasannejad-Bibalan M, Jalalifar S, Fathi J, Ebrahim-Saraie HS. Burden of Clostridium (Clostridioides) difficile infection among patients in Western Asia: a systematic review and meta-analysis. Iran J Public Health. 2019;48(9):1589–99.
PubMed
PubMed Central
Google Scholar
Al Assaad R, Dakessian A, Bachir R, Bizri AR, El Sayed M. Significance of Clostridium difficile in community-acquired diarrhea in a tertiary care center in Lebanon. Sci Rep. 2020;10(1):5678. https://doi.org/10.1038/s41598-020-62418-9.
Article
CAS
PubMed
PubMed Central
Google Scholar
Karaoui WR, Rustam LBO, Bou Daher H, Rimmani HH, Rasheed SS, Matar GM, et al. Incidence, outcome, and risk factors for recurrence of nosocomial Clostridioides difficile infection in adults: a prospective cohort study. J Infect Public Health. 2020;13(4):485–90. https://doi.org/10.1016/j.jiph.2019.11.005.
Article
PubMed
Google Scholar
Azimirad M, Krutova M, Yadegar A, Shahrokh S, Olfatifar M, Aghdaei HA, et al. Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study. Emerg Microbes Infect. 2020;9(1):1432–43. https://doi.org/10.1080/22221751.2020.1780949.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jamal WY, Rotimi VO. Surveillance of antibiotic resistance among hospital- and community-acquired toxigenic Clostridium difficile Isolates over 5-year period in Kuwait. PLoS ONE. 2016;11(8):e0161411. https://doi.org/10.1371/journal.pone.0161411.
Article
CAS
PubMed
PubMed Central
Google Scholar
National Healthcare Safety Network. Multidrug-Resistant Organism and Clostridioides difficile Infection (MDRO/CDI) Module. Centers for Disease Control and Prevention, Atlanta, GA. 2021. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf.
Biosynex Group. IMMUNOQUICK®: Clostridium difficile GDH and Tox A/B product catalog. Strasbourg Cedex, France. 2015.
Centers for Disease Control and Prevention. Antimicrobial Use and Resistance (AUR) Module. Atlanta, GA. 2020.
Hung YP, Lin HJ, Wu TC, Liu HC, Lee JC, Lee CI, et al. Risk factors of fecal toxigenic or non-toxigenic Clostridium difficile colonization: impact of Toll-like receptor polymorphisms and prior antibiotic exposure. PLoS ONE. 2013;8(7):e69577. https://doi.org/10.1371/journal.pone.0069577.
Article
CAS
PubMed
PubMed Central
Google Scholar
Marciniak C, Chen D, Stein AC, Semik PE. Prevalence of Clostridium difficile colonization at admission to rehabilitation. Arch Phys Med Rehabil. 2006;87(8):1086–90. https://doi.org/10.1016/j.apmr.2006.03.020.
Article
PubMed
Google Scholar
Aljafel NA, Al-Shaikhy HH, Alnahdi MA, Thabit AK. Incidence of Clostridioides difficile infection at a Saudi Tertiary Academic Medical Center and compliance with IDSA/SHEA, ACG, and ESCMID guidelines for treatment over a 10-year period. J Infect Public Health. 2020. https://doi.org/10.1016/j.jiph.2020.03.007.
Article
PubMed
Google Scholar
Ofori E, Ramai D, Dhawan M, Mustafa F, Gasperino J, Reddy M. Community-acquired Clostridium difficile: epidemiology, ribotype, risk factors, hospital and intensive care unit outcomes, and current and emerging therapies. J Hosp Infect. 2018;99(4):436–42. https://doi.org/10.1016/j.jhin.2018.01.015.
Article
CAS
PubMed
Google Scholar
Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA internal medicine. 2013;173(14):1359–67. https://doi.org/10.1001/jamainternmed.2013.7056.
Article
PubMed
Google Scholar
Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23):2989–95. https://doi.org/10.1001/jama.294.23.2989.
Article
CAS
PubMed
Google Scholar
Blot E, Escande MC, Besson D, Barbut F, Granpeix C, Asselain B, et al. Outbreak of Clostridium difficile-related diarrhoea in an adult oncology unit: risk factors and microbiological characteristics. J Hosp Infect. 2003;53(3):187–92.
Article
CAS
Google Scholar
Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin North Am. 2010;94(1):135–53. https://doi.org/10.1016/j.mcna.2009.08.013.
Article
CAS
PubMed
Google Scholar
Alalawi M, Aljahdali S, Alharbi B, Fagih L, Fatani R, Aljuhani O. Clostridium difficile infection in an academic medical center in Saudi Arabia: prevalence and risk factors. Ann Saudi Med. 2020;40(4):305–9. https://doi.org/10.5144/0256-4947.2020.305.
Article
PubMed
PubMed Central
Google Scholar
Al Otaibi H, Ahmed AE, Alammari M. Association between omeprazole use and Clostridium difficile infection among hospitalized patients: A case-control study of the Saudi population. Qatar Med J. 2017;2017(2):2. https://doi.org/10.5339/qmj.2017.2.
Article
PubMed
PubMed Central
Google Scholar
Alanazi MQ, Salam M, Alqahtani FY, Ahmed AE, Alenaze AQ, Al-Jeraisy M, et al. An evaluation of antibiotics prescribing patterns in the Emergency Department of a Tertiary Care Hospital in Saudi Arabia. Infect Drug Resist. 2019;12:3241–7. https://doi.org/10.2147/IDR.S211673.
Article
CAS
PubMed
PubMed Central
Google Scholar
Al-Tawfiq JA, Momattin H, Hinedi K. Empiric antibiotic therapy in the treatment of community-acquired pneumonia in a General Hospital in Saudi Arabia. J Glob Infect Dis. 2019;11(2):69–72. https://doi.org/10.4103/jgid.jgid_84_18.
Article
PubMed
PubMed Central
Google Scholar
Yu J, Wang G, Davidson A, Chow I, Chiu A. Antibiotics utilization for community acquired pneumonia in a Community Hospital Emergency Department. J Pharm Pract. 2020. https://doi.org/10.1177/0897190020953032.
Article
PubMed
Google Scholar
Orlando V, Monetti VM, Moreno Juste A, Russo V, Mucherino S, Trama U, et al. Drug utilization pattern of antibiotics: the role of age, sex and municipalities in determining variation. Risk ManagHealthc Policy. 2020;13:63–71. https://doi.org/10.2147/RMHP.S223042.
Article
Google Scholar
Patra SK, Mishra SB, Rath A, Samal S, Iqbal SN. Study of antimicrobial utilization and cost of therapy in medicine intensive care unit of a tertiary care hospital in Eastern India. Indian J Crit Care Med. 2020;24(10):938–42. https://doi.org/10.5005/jp-journals-10071-23552.
Article
PubMed
PubMed Central
Google Scholar
Trikha S, Dalpath SK, Sharma M, Shafiq N. Antibiotic prescribing patterns and knowledge of antibiotic resistance amongst the doctors working at public health facilities of a state in northern India: a cross sectional study. J Family Med Prim Care. 2020;9(8):3937–43. https://doi.org/10.4103/jfmpc.jfmpc_367_20.
Article
PubMed
PubMed Central
Google Scholar
Jarab AS, Mukattash TL, Nusairat B, Shawaqfeh M, Farha RA. Patterns of antibiotic use and administration in hospitalized patients in Jordan. Saudi Pharm J. 2018;26(6):764–70. https://doi.org/10.1016/j.jsps.2018.04.009.
Article
PubMed
PubMed Central
Google Scholar
AkdemIr Kalkan I, Cinar G, PehlIvanli A, Urkmez F, TopaloGlu IE, Akyol B, et al. Pattern of systemic antibiotic use and potential drug interactions: evaluations through a point prevalence study in Ankara University Hospitals. Turk J Med Sci. 2020. https://doi.org/10.3906/sag-2004-164.
Article
PubMed
Google Scholar
Thabit AK, Shea KM, Guzman OE, Garey KW. Antibiotic utilization within 18 community hospitals in the United States: A 5-year analysis. Pharmacoepidemiol Drug Saf. 2020. https://doi.org/10.1002/pds.5156.
Article
PubMed
Google Scholar
Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated Clostridium difficile infection. Antimicrob Agents Chemother. 2013;57(5):2326–32. https://doi.org/10.1128/AAC.02176-12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Deshpande A, Pasupuleti V, Thota P, Pant C, Rolston DD, Sferra TJ, et al. Community-associated Clostridium difficile infection and antibiotics: a meta-analysis. J Antimicrob Chemother. 2013;68(9):1951–61. https://doi.org/10.1093/jac/dkt129.
Article
CAS
PubMed
Google Scholar